These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9223150

  • 1. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP, Scholtes NC, Kleuskens JA, Bos HJ.
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH, Kleuskens J, Scholtes N, Bos HJ.
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination of dogs against Babesia canis infection.
    Schetters TP, Kleuskens JA, Scholtes NC, Pasman JW, Goovaerts D.
    Vet Parasitol; 1997 Dec 15; 73(1-2):35-41. PubMed ID: 9477490
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis.
    Schetters TP, Kleuskens JA, Scholtes NC, Pasman JW, Bos HJ.
    Vet Parasitol; 1994 Apr 15; 52(3-4):219-33. PubMed ID: 8073606
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Soluble parasite antigens from Babesia canis do not directly activate the kallikrein system in dogs infected with Babesia canis.
    Finizio AL, Kleuskens JA, Van De Crommert J, Gorenflot A, Carcy B, Schetters TP.
    Vet Parasitol; 2011 Mar 10; 176(2-3):132-8. PubMed ID: 21130577
    [Abstract] [Full Text] [Related]

  • 15. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
    Sunaga F, Arai S, Itoh S, Taharaguchi S.
    Parasitol Res; 2014 May 10; 113(5):1681-6. PubMed ID: 24535736
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.
    Fukumoto S, Tamaki Y, Shirafuji H, Harakawa S, Suzuki H, Xuan X.
    Clin Diagn Lab Immunol; 2005 Apr 10; 12(4):557-9. PubMed ID: 15817768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells.
    Fukumoto S, Xuan X, Takabatake N, Igarashi I, Sugimoto C, Fujisaki K, Nagasawa H, Mikami T, Suzuki H.
    Infect Immun; 2004 Mar 10; 72(3):1795-8. PubMed ID: 14977989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.